The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...

Dow Jones Top Company Headlines at 11 AM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | JPMorgan ... The move raises privacy concerns as the drugmaker takes control of the genetic ...

The private equity owner of Northwind Midstream is exploring a potential sale of the Permian Basin gas infrastructure ...

The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

The Dow Jones Industrial Average finished up 0.3 per cent at 42,792.07. Read more at straitstimes.com. Read more at ...

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

The FTSE 100 , US markets and European stocks floundered on Monday, despite a new deal struck between the EU and UK, as ...

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

BioRewards Plasma Services ("BioRewards"), a next-generation plasma collection company, has officially launched with the backing of Alpha-1 Plasma Holdings ("Alpha-1"), a premier investor in plasma ...